Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-minocycline quadruple therapy for Helicobacter pylori eradication in penicillin-allergic patients
ChiCTR2500107101Phase 4Recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan in Helicobacter pylori infection (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: H. pylori eradication rate. Started Aug 2025; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2500107101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107101.